The Vitamin D3 product type segment was estimated to account for more than 70% value share in 2016, while the Vitamin D2 product type segment was estimated to hold close to 30% value share in 2016. This segment is expected to lose more than 600 BPS during 2016 – 2026 and is expected to account for more than 20% value share by 2026. The Vitamin D3 segment is forecast to be valued at more than US$ 2,000 Mn by the end of 2026, registering a CAGR of 12.0% between 2016 and 2026.
